Apollo
logo
  1. Home
  2. Medicine
  3. Folitrax-15 Tablet 5's
  4. Health Queries for Folitrax-15 Tablet 5's
  5. Based on my history of taking HCQS-400, Mexate, Folitrax, and currently Rumalef 10 mg daily, and my recent lab reports showing high inflammation (CRP of 503) but normal liver function (SGOT/SGPT of 26/34), which disease-modifying antirheumatic drugs (DMARDs) would be the most suitable option for me?

health query

Have a query?

Based on my history of taking HCQS-400, Mexate, Folitrax, and currently Rumalef 10 mg daily, and my recent lab reports showing high inflammation (CRP of 503) but normal liver function (SGOT/SGPT of 26/34), which disease-modifying antirheumatic drugs (DMARDs) would be the most suitable option for me?

Asked by Male, 65 · 20 days ago

Since your current dose of leflunomide (Rumalef) isn't fully controlling the inflammation, your rheumatologist has several excellent options. They may consider safely increasing your leflunomide dose, combining it with hydroxychloroquine, or transitioning you to biologic DMARDs or JAK inhibitors, which are highly effective at targeting stubborn inflammation. Because your liver is doing so well, you have many safe pathways forward. Please share these results with your specialist soon so they can adjust your plan and help you find relief.
user icon

Ask Apollo

AI powered Health Chatbot

Based on my history of taking HCQS-400, Mexate, Folitrax, and currently Rumalef 10 mg daily, and my recent lab reports showing high inflammation (CRP of 503) but normal liver function (SGOT/SGPT of 26/34), which disease-modifying antirheumatic drugs (DMARDs) would be the most suitable option for me?

Answered 20 days ago